ACADIA Pharmaceuticals (ACAD) Cash Flow: Operating & Free Cash Flow

ACADIA Pharmaceuticals Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for ACADIA Pharmaceuticals Inc. (ACAD) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Operating Activities
Net Income	391.00	226.45	-61.29	-215.98	-167.87	-281.58	-235.26	-245.19	-289.40
Depreciation & Amortization	11.76	15.88	5.55	2.03	3.34	2.93	2.77	3.01	2.71
Deferred Income Tax	-249.88	0.00	0.00	0.00	0.00	2.75	0.00	0.00	0.00
Stock Based Compensation	0.00	67.05	66.42	68.20	63.62	84.42	82.27	81.56	75.53
Change in Working Capital	-89.76	4.16	18.13	37.99	-24.82	11.04	3.71	-8.20	-6.41
Change in Accounts Receivable	-43.54	-2.35	-39.27	2.26	-16.12	-12.47	-9.69	-8.75	-11.44
Change in Inventory	-18.20	-49.55	-28.81	2.42	-4.21	-3.32	-1.74	1.93	-1.01
Change in Accounts Payable	-5.29	-1.35	4.80	5.87	-1.62	1.27	4.06	-5.62	4.87
Change in Other Working Capital	-22.73	57.40	-11.76	27.44	-2.88	25.55	11.08	4.24	1.17
Other Operating Activities	46.71	-155.82	-12.12	-6.28	0.08	44.28	-4.61	1.35	-0.29
Net Cash from Operating Activities	109.84	157.72	16.70	-114.04	-125.66	-136.17	-151.13	-167.47	-217.86
Investing Activities
Capital Expenditures	-4.69	-0.52	-0.05	0.00	-1.12	-7.59	-1.13	-2.15	-0.81
Acquisitions	0.00	0.00	-40.00	0.00	69.98	-200.10	164.71	0.04	0.00
Purchases of Investments	-692.57	-505.10	-369.99	-363.17	-492.80	-339.91	-578.63	-331.06	-478.82
Sales/Maturities of Investments	493.53	328.57	442.03	436.42	422.82	540.00	413.93	261.68	572.10
Other Investing Activities	0.00	146.52	32.05	0.00	-69.98	200.10	-164.71	0.04	93.29
Net Cash from Investing Activities	-302.56	-30.54	32.00	73.24	-71.10	192.51	-165.84	-71.49	92.47
Financing Activities
Common Stock Issued	49.88	6.85	25.13	8.20	18.16	81.00	371.85	306.65	31.19
Net Cash from Financing Activities	49.88	6.85	25.13	8.20	18.16	81.00	371.85	306.65	31.19
Summary
Effect of Forex Changes on Cash	0.95	-0.09	-0.02	0.01	0.01	-0.01	0.00	0.00	-0.01
Net Change in Cash	-141.89	133.93	73.81	-32.59	-178.59	137.33	54.88	67.69	-94.20
Cash at Beginning of Period	319.59	194.43	120.62	153.21	331.80	194.47	139.58	71.89	163.62
Cash at End of Period	177.70	328.36	194.43	120.62	153.21	331.80	194.47	139.58	69.42
Free Cash Flow	105.15	157.20	16.65	-114.04	-126.78	-143.75	-152.26	-169.62	-218.67
Supplemental Disclosures
Income Taxes Paid	-	19.52	5.85	2.19	1.04	1.11	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ACADIA Pharmaceuticals Cash Flow

What is ACADIA Pharmaceuticals's free cash flow?

ACADIA Pharmaceuticals generated free cash flow of $105.15M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $109.84M minus $4.69M of capital expenditures. That was down 33.1% from $157.20M a year earlier. Free cash flow equaled 9.8% of revenue.

How much does ACADIA Pharmaceuticals spend on capital expenditures?

ACADIA Pharmaceuticals spent $4.69M on capital expenditures in fiscal 2025, compared with $523.00K a year earlier. That equals 4.3% of operating cash flow.

Does ACADIA Pharmaceuticals pay dividends or buy back shares?

ACADIA Pharmaceuticals's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition